Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
August 6, 2018
Neovasc Announces Publication of Safety and Efficacy Results from REDUCE Study in International Journal of Cardiology
VANCOUVER, Aug. 6, 2018 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NVCN) (NVCN.TO), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, ...
August 6, 2018
Eiger BioPharmaceuticals Announces First Patient Enrolled in Phase 2 LIFT Study of Pegylated Interferon Lambda in Combination with Ritonavir-Boosted Lonafarnib at National Institutes of Health
PALO ALTO, Calif., Aug. 6, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced ...
August 6, 2018
STRATA Skin Sciences Announces FDA Granted 510(k) Clearance for the Multi Micro Dose™ Tip for its XTRAC® 308nm Excimer Laser
HORSHAM, Pa., Aug. 06, 2018 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, ...
August 6, 2018
Krystal Biotech Reports Second Quarter 2018 Financial Results and Provides Corporate Update
PITTSBURGH, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech (KRYS), a gene therapy company advancing  “off-the-shelf” topical and intra-dermal treatments for skin diseases, today reported ...
August 6, 2018
Fortress Biotech Announces Aevitas Therapeutics Enters Sponsored Research Agreement with the University of Pennsylvania to Advance AAV Gene Therapy Technology
NEW YORK, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech (FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology ...
August 3, 2018
CMS Grants New Technology Add-on Payment to ZEMDRI™ (plazomicin)
SOUTH SAN FRANCISCO, Calif., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address ...
August 3, 2018
Athenex, Inc. to Report Second Quarter Earnings Results on August 14, 2018
BUFFALO, N.Y., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies ...
August 3, 2018
HTG Molecular Diagnostics and Oncologie, Inc. Complete Master Agreement to Partner on Biomarker Development for Immuno-oncology Drug Development
TUCSON, Ariz., Aug. 03, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications ...
July 30, 2018
4D Announces Publication of Data Showing Potential of Single Bacterial Strains From the Human Gut Microbiota to Serve as Novel HDAC Inhibitors
LEEDS, United Kingdom, July 30, 2018 (GLOBE NEWSWIRE) -- 4D pharma plc (DDDD.L), a pharmaceutical company leading the development of live biotherapeutics, today announces the ...
July 30, 2018
RedHill Biopharma Announces Positive Top-Line Results from Phase III Study of RHB-104 in Crohn’s Disease
TEL-AVIV, Israel and RALEIGH, N.C., July 30, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company ...
July 30, 2018
Tyme Technologies Provides Clinical and Corporate Update for Fiscal 1Q 2019
NEW YORK, July 30, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (TYME), a clinical-stage oncology company developing metabolically-based cancer therapeutics, today announced a clinical and ...
July 30, 2018
Kitov Announces Settlement of Shareholder Class Action Litigation
Tel Aviv, Israel, July 30, 2018 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (Nasdaq: KTOV; TASE: KTOV.TA), an innovative biopharmaceutical company, today announced that it has ...
July 30, 2018
BioDelivery Sciences Appoints Thomas Smith, MD as Chief Medical Officer Further Expanding Company’s Expertise in Field of Pain Management
RALEIGH, N.C., July 30, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (BDSI), a leading commercial based specialty pharmaceutical company focused on patients living with ...
July 30, 2018
Soleno Therapeutics Receives Fast Track Designation from FDA for DCCR for Treatment of Prader-Willi Syndrome
REDWOOD CITY, Calif., July 30, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of ...
July 30, 2018
Pernix Therapeutics Announces Successful Closing of Transaction Regarding Worldwide Rights to Contrave® for Weight Loss
MORRISTOWN, N.J., July 30, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (PTX), a specialty pharmaceutical company, today announced the closing of a transaction in ...
July 30, 2018
DURECT Announces FDA Approval of Indivior's PERSERIS™ (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults
CUPERTINO, Calif., July 30, 2018 /PRNewswire/ -- DURECT Corporation (DRRX) today announced that Indivior PLC (INDV.L) has reported that the U.S. Food and Drug Administration (FDA) has approved ...
July 30, 2018
Advaxis Announces FDA Allowance of IND Application for ADXS-HOT Drug Candidate for Non-Small Cell Lung Cancer
Advaxis, Inc. (ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced that the U.S. Food and Drug Administration ...
July 30, 2018
AIT Therapeutics Announces Start of Manufacturing of Ventilator Compatible NO Generator and Delivery System
GARDEN CITY, N.Y. and REHOVOT, Israel, July 30, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (AITB), a clinical-stage medical device and biopharmaceutical company focused on ...
July 27, 2018
Achaogen Announces Strategic Update to Align Operations with Commercial and Clinical Development Priorities
SOUTH SAN FRANCISCO, Calif., July 26, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a biopharmaceutical company developing and commercializing innovative antibacterial agents to address multi-drug ...
July 27, 2018
MannKind Corporation to Hold 2018 Second Quarter Financial Results Conference Call on August 2, 2018
WESTLAKE VILLAGE, Calif., July 27, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (MNKD) will host a conference call to discuss the 2018 second quarter and year-to-date ...
Page 76 of 169